These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

428 related items for PubMed ID: 19091851

  • 1. Intravitreal bevacizumab to treat subfoveal choroidal neovascularisation in highly myopic eyes: 1-year outcome.
    Ruiz-Moreno JM, Montero JA, Gomez-Ulla F, Ares S.
    Br J Ophthalmol; 2009 Apr; 93(4):448-51. PubMed ID: 19091851
    [Abstract] [Full Text] [Related]

  • 2. Intravitreous bevacizumab to treat subfoveal choroidal neovascularization in highly myopic eyes: short-term results.
    Ruiz-Moreno JM, Gomez-Ulla F, Montero JA, Ares S, Lopez-Lopez F, Rodriguez M, Fernandez M.
    Eye (Lond); 2009 Feb; 23(2):334-8. PubMed ID: 18064056
    [Abstract] [Full Text] [Related]

  • 3. Intravitreal bevacizumab (Avastin) for myopic choroidal neovascularization: six-month results of a prospective pilot study.
    Chan WM, Lai TY, Liu DT, Lam DS.
    Ophthalmology; 2007 Dec; 114(12):2190-6. PubMed ID: 17599414
    [Abstract] [Full Text] [Related]

  • 4. Intravitreal bevacizumab therapy on an as-per-needed basis in subfoveal choroidal neovascularization secondary to pathological myopia: 2-year outcomes of a prospective case series.
    Iacono P, Parodi MB, Papayannis A, Kontadakis S, Sheth S, Bandello F.
    Retina; 2011 Oct; 31(9):1841-7. PubMed ID: 21775926
    [Abstract] [Full Text] [Related]

  • 5. Intravitreal bevacizumab treatment for choroidal neovascularization in pathologic myopia: 12-month results.
    Gharbiya M, Allievi F, Mazzeo L, Gabrieli CB.
    Am J Ophthalmol; 2009 Jan; 147(1):84-93.e1. PubMed ID: 18774547
    [Abstract] [Full Text] [Related]

  • 6. Intravitreal bevacizumab (Avastin) for myopic choroidal neovascularisation: 1-year results of a prospective pilot study.
    Chan WM, Lai TY, Liu DT, Lam DS.
    Br J Ophthalmol; 2009 Feb; 93(2):150-4. PubMed ID: 18801766
    [Abstract] [Full Text] [Related]

  • 7. Intravitreal bevacizumab for subfoveal choroidal neovascularization in age-related macular degeneration at twenty-four months: the Pan-American Collaborative Retina Study.
    Arevalo JF, Sánchez JG, Wu L, Berrocal MH, Alezzandrini AA, Restrepo N, Maia M, Farah ME, Brito M, Díaz-Llopis M, Rodríguez FJ, Reategui G, Iturralde-Iraola J, Udaondo-Mirete P, Pan-American Collaborative Retina Study Group.
    Ophthalmology; 2010 Oct; 117(10):1974-81, 1981.e1. PubMed ID: 20569989
    [Abstract] [Full Text] [Related]

  • 8. Intravitreal bevacizumab to treat myopic choroidal neovascularization: 2-year outcome.
    Ruiz-Moreno JM, Montero JA.
    Graefes Arch Clin Exp Ophthalmol; 2010 Jul; 248(7):937-41. PubMed ID: 20221624
    [Abstract] [Full Text] [Related]

  • 9. Twelve-month outcome after one intravitreal injection of bevacizumab to treat myopic choroidal neovascularization.
    Ruiz-Moreno JM, Montero JA, Arias L, Araiz J, Gomez-Ulla F, Silva R, Piñero DP.
    Retina; 2010 Jul; 30(10):1609-15. PubMed ID: 20856171
    [Abstract] [Full Text] [Related]

  • 10. Prognostic factors of eyes with naïve subfoveal myopic choroidal neovascularization after intravitreal bevacizumab.
    Yang HS, Kim JG, Kim JT, Joe SG.
    Am J Ophthalmol; 2013 Dec; 156(6):1201-1210.e2. PubMed ID: 24075429
    [Abstract] [Full Text] [Related]

  • 11. Intravitreal bevacizumab (Avastin) as treatment for subfoveal choroidal neovascularisation secondary to pathological myopia.
    Yamamoto I, Rogers AH, Reichel E, Yates PA, Duker JS.
    Br J Ophthalmol; 2007 Feb; 91(2):157-60. PubMed ID: 16870653
    [Abstract] [Full Text] [Related]

  • 12. Primary intravitreal bevacizumab for subfoveal choroidal neovascularization in age-related macular degeneration: results of the Pan-American Collaborative Retina Study Group at 12 months follow-up.
    Arevalo JF, Fromow-Guerra J, Sanchez JG, Maia M, Berrocal MH, Wu L, Saravia MJ, Costa RA, Pan-American Collaborative Retina Study Group.
    Retina; 2008 Feb; 28(10):1387-94. PubMed ID: 18827735
    [Abstract] [Full Text] [Related]

  • 13. Intravitreal bevacizumab for treatment-naïve subfoveal occult choroidal neovascularization in age-related macular degeneration.
    Furino C, Boscia F, Recchimurzo N, Besozzi G, Cardascia N, Sborgia L, Niro A, Sborgia C.
    Acta Ophthalmol; 2009 Jun; 87(4):404-7. PubMed ID: 18782335
    [Abstract] [Full Text] [Related]

  • 14. Intravitreal bevacizumab for previously treated choroidal neovascularization from age-related macular degeneration.
    Goff MJ, Johnson RN, McDonald HR, Ai E, Jumper JM, Fu A.
    Retina; 2007 Jun; 27(4):432-8. PubMed ID: 17420694
    [Abstract] [Full Text] [Related]

  • 15. Intravitreal bevacizumab for subfoveal choroidal neovascularization associated with pattern dystrophy.
    Parodi MB, Iacono P, Cascavilla M, Zucchiatti I, Kontadakis DS, Bandello F.
    Invest Ophthalmol Vis Sci; 2010 Sep; 51(9):4358-61. PubMed ID: 20375343
    [Abstract] [Full Text] [Related]

  • 16. Intravitreal bevacizumab for treatment of myopic choroidal neovascularization: the second year of a prospective study.
    Gharbiya M, Allievi F, Conflitti S, Esposito M, Scavella V, Moramarco A, Cruciani F.
    Clin Ter; 2010 Sep; 161(3):e87-93. PubMed ID: 20589348
    [Abstract] [Full Text] [Related]

  • 17. Intravitreal injection of bevacizumab for choroidal neovascularisation associated with pathological myopia.
    Sakaguchi H, Ikuno Y, Gomi F, Kamei M, Sawa M, Tsujikawa M, Oshima Y, Kusaka S, Tano Y.
    Br J Ophthalmol; 2007 Feb; 91(2):161-5. PubMed ID: 16914470
    [Abstract] [Full Text] [Related]

  • 18. Intravitreal bevacizumab for choroidal neovascularisation associated with pseudoxanthoma elasticum.
    Finger RP, Charbel Issa P, Ladewig M, Holz FG, Scholl HP.
    Br J Ophthalmol; 2008 Apr; 92(4):483-7. PubMed ID: 18369065
    [Abstract] [Full Text] [Related]

  • 19. Single-session photodynamic therapy combined with intravitreal bevacizumab and triamcinolone for neovascular age-related macular degeneration.
    Ahmadieh H, Taei R, Soheilian M, Riazi-Esfahani M, Karkhaneh R, Lashay A, Azarmina M, Dehghan MH, Moradian S.
    BMC Ophthalmol; 2007 Jun 07; 7():10. PubMed ID: 17555600
    [Abstract] [Full Text] [Related]

  • 20. Intravitreal bevacizumab for treatment of subfoveal idiopathic choroidal neovascularization: results of a 1-year prospective trial.
    Zhang H, Liu ZL, Sun P, Gu F.
    Am J Ophthalmol; 2012 Feb 07; 153(2):300-306.e1. PubMed ID: 21982109
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.